Bankrolled by Pfizer and Bayer, Pyxis files for $100M IPO to take cancer drugs into the clinic
Bankrolled by Pfizer and Bayer, Pyxis files for $100M IPO [...]
Bankrolled by Pfizer and Bayer, Pyxis files for $100M IPO [...]
ESMO: Mirati pulls away from Amgen in colorectal cancer with [...]
AstraZeneca taps Dana-Farber’s Rahma to lead its GI oncology work [...]
ESMO: Daiichi unveils first early peek at next-gen ADC as [...]
New insights into bats’ immunity could point to therapeutic approaches [...]
ESMO: Novartis links prostate cancer drug to improved pain, quality [...]
ESMO: Zymeworks lays down marker in fight to unseat Herceptin [...]
Aerie tries to wash over failure of midstage eye disease [...]
How do faulty genes drive cancer? There’s a surprising immune [...]
Newly discovered immune cells block melanoma metastasis in mice and [...]